Cochlear | COH - Sales Revenues

Stock Price
250.17
Daily Change
-8.57 -3.31%
Monthly
-4.74%
Yearly
-19.25%
Q1 Forecast
263.64

Cochlear reported AUD585.65M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
Avita Medical AUD 18.42M 14K Jun/2025
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Healius AUD 933.9M 485.3M Dec/2024
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 195.04M 20.71M Jun/2025
Mesoblast USD 13.2M 10.04M Jun/2025
Monash IVF AUD 65.77M 74.54M Jun/2025
Nanosonics AUD 105.03M 11.44M Jun/2025
Polynovo AUD 34.58M 24.94M Jun/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
Regis Healthcare AUD 619.06M 37.36M Dec/2024
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 4.98B 311M Jun/2025
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025